Skip to main content
Equibles

Aoife Brennan, M.D.

Board Member

Xilio Therapeutics, Inc. (XLO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Xilio Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get XLO alerts

About Aoife Brennan, M.D.

Aoife Brennan, M.D. is recorded as Board Member at Xilio Therapeutics, Inc. (XLO) since June 13, 2024. Xilio Therapeutics, Inc. reported in an 8-K filed June 13, 2024 that Aoife Brennan, M.D. was appointed Class III director, effective June 13, 2024. Xilio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Xilio Therapeutics, Inc. includes René Russo (CEO and Board Member), Sara M. Bonstein (Chairman and Board Member), Kevin Brennan (CFO and Chief Accounting Officer) and 7 others.

“and, on the recommendation of the Nominating and Corporate Governance Committee of the Board, elected James Shannon, M.D., as a Class I director of the Company, with a term expiring at the Company's 2025 annual meeting of stockholders, and Aoife Brennan, M.D., as a Class III director of the Company, with a term expiring at the Company's 2027 annual meeting of stockholders”
Xilio Therapeutics, Inc. Form 8-K, filed June 13, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Xilio Therapeutics, Inc.

Recent activity